Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C Becker

Showing results (131-140 of 436) with videos related to

Pageof 44
Sort By:
Annals of Neurology|December 11, 2008
Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapyElaine M Hylek, Richard C Becker
Nature Reviews. Cardiology|February 22, 2012
Oral factor Xa inhibitors for the long-term management of ACSJames W Wisler, Richard C Becker
Journal of Thrombosis and Thrombolysis|August 10, 2013
Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversalLarry R Jackson, Richard C Becker
Expert Opinion on Therapeutic Targets|October 28, 2014
Antithrombotic therapy: new areas to understand efficacy and bleedingJames W Wisler, Richard C Becker
Journal of Thrombosis and Thrombolysis|November 4, 2021
International COVID-19 biomarkers colloquiumRichard C Becker, Diana A Gorog
Journal of Thrombosis and Thrombolysis|April 25, 2024
The foundation for investigating factor XI as a target for inhibition in human cardiovascular diseaseAhmed E Ali, Richard C Becker
Journal of Thrombosis and Thrombolysis|June 13, 2020
Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvementDiana A Gorog, Richard C Becker
Drugs|September 15, 2010
Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555Sergio Leonardi, Pierluigi Tricoci, Richard C Becker
Current Opinion in Molecular Therapeutics|April 14, 2006
Nucleic acid aptamers as adjuncts to vaccine developmentKristian C D Becker, Richard C Becker
Journal of Thrombosis and Thrombolysis|August 5, 2021
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesiclesRichard C Becker, Travis Sexton, Susan Smyth, et al.
Pageof 44

Showing results (131-140 of 436) with videos related to

Sort By:
Pageof 44
Annals of Neurology|December 11, 2008
Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapyElaine M Hylek, Richard C Becker
Nature Reviews. Cardiology|February 22, 2012
Oral factor Xa inhibitors for the long-term management of ACSJames W Wisler, Richard C Becker
Journal of Thrombosis and Thrombolysis|August 10, 2013
Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversalLarry R Jackson, Richard C Becker
Expert Opinion on Therapeutic Targets|October 28, 2014
Antithrombotic therapy: new areas to understand efficacy and bleedingJames W Wisler, Richard C Becker
Journal of Thrombosis and Thrombolysis|November 4, 2021
International COVID-19 biomarkers colloquiumRichard C Becker, Diana A Gorog
Journal of Thrombosis and Thrombolysis|April 25, 2024
The foundation for investigating factor XI as a target for inhibition in human cardiovascular diseaseAhmed E Ali, Richard C Becker
Journal of Thrombosis and Thrombolysis|June 13, 2020
Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvementDiana A Gorog, Richard C Becker
Drugs|September 15, 2010
Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555Sergio Leonardi, Pierluigi Tricoci, Richard C Becker
Current Opinion in Molecular Therapeutics|April 14, 2006
Nucleic acid aptamers as adjuncts to vaccine developmentKristian C D Becker, Richard C Becker
Journal of Thrombosis and Thrombolysis|August 5, 2021
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesiclesRichard C Becker, Travis Sexton, Susan Smyth, et al.
Pageof 44